Intravitreal Toxicity of Hydroxyacyclovir (bw-b759u), a New Antiviral Agent

Jose S Pulido, Gholam A. Peyman, Timothy Lesar, Jackie Vernot

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

We investigated the toxicity of the antiviral compound hydroxyacyclovir (9-[hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine, or BW-B759U), following intravitreal injection in the rabbit. Intravitreal doses of 10, 20, 40, 80, 100, 200, and 400 μg produced no discernible ophthalmoscopic or histologic changes. Intravitreal doses of 40, 200, and 400 μg produced no changes in the electroretinography B-waves. The low level of retinal toxicity and excellent median inhibitory dose values of intravitreal BW-B759U against cytomegalovirus suggest its potential therapeutic utility in the treatment of cytomegalovirus retinitis.

Original languageEnglish (US)
Pages (from-to)840-841
Number of pages2
JournalArchives of Ophthalmology
Volume103
Issue number6
DOIs
StatePublished - 1985
Externally publishedYes

Fingerprint

Antiviral Agents
Cytomegalovirus Retinitis
Electroretinography
Intravitreal Injections
Guanine
Cytomegalovirus
Rabbits
Therapeutics

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Intravitreal Toxicity of Hydroxyacyclovir (bw-b759u), a New Antiviral Agent. / Pulido, Jose S; Peyman, Gholam A.; Lesar, Timothy; Vernot, Jackie.

In: Archives of Ophthalmology, Vol. 103, No. 6, 1985, p. 840-841.

Research output: Contribution to journalArticle

Pulido, Jose S ; Peyman, Gholam A. ; Lesar, Timothy ; Vernot, Jackie. / Intravitreal Toxicity of Hydroxyacyclovir (bw-b759u), a New Antiviral Agent. In: Archives of Ophthalmology. 1985 ; Vol. 103, No. 6. pp. 840-841.
@article{9fbc91f126af4d96b1354e5b6079b518,
title = "Intravitreal Toxicity of Hydroxyacyclovir (bw-b759u), a New Antiviral Agent",
abstract = "We investigated the toxicity of the antiviral compound hydroxyacyclovir (9-[hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine, or BW-B759U), following intravitreal injection in the rabbit. Intravitreal doses of 10, 20, 40, 80, 100, 200, and 400 μg produced no discernible ophthalmoscopic or histologic changes. Intravitreal doses of 40, 200, and 400 μg produced no changes in the electroretinography B-waves. The low level of retinal toxicity and excellent median inhibitory dose values of intravitreal BW-B759U against cytomegalovirus suggest its potential therapeutic utility in the treatment of cytomegalovirus retinitis.",
author = "Pulido, {Jose S} and Peyman, {Gholam A.} and Timothy Lesar and Jackie Vernot",
year = "1985",
doi = "10.1001/archopht.1985.01050060100036",
language = "English (US)",
volume = "103",
pages = "840--841",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "6",

}

TY - JOUR

T1 - Intravitreal Toxicity of Hydroxyacyclovir (bw-b759u), a New Antiviral Agent

AU - Pulido, Jose S

AU - Peyman, Gholam A.

AU - Lesar, Timothy

AU - Vernot, Jackie

PY - 1985

Y1 - 1985

N2 - We investigated the toxicity of the antiviral compound hydroxyacyclovir (9-[hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine, or BW-B759U), following intravitreal injection in the rabbit. Intravitreal doses of 10, 20, 40, 80, 100, 200, and 400 μg produced no discernible ophthalmoscopic or histologic changes. Intravitreal doses of 40, 200, and 400 μg produced no changes in the electroretinography B-waves. The low level of retinal toxicity and excellent median inhibitory dose values of intravitreal BW-B759U against cytomegalovirus suggest its potential therapeutic utility in the treatment of cytomegalovirus retinitis.

AB - We investigated the toxicity of the antiviral compound hydroxyacyclovir (9-[hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine, or BW-B759U), following intravitreal injection in the rabbit. Intravitreal doses of 10, 20, 40, 80, 100, 200, and 400 μg produced no discernible ophthalmoscopic or histologic changes. Intravitreal doses of 40, 200, and 400 μg produced no changes in the electroretinography B-waves. The low level of retinal toxicity and excellent median inhibitory dose values of intravitreal BW-B759U against cytomegalovirus suggest its potential therapeutic utility in the treatment of cytomegalovirus retinitis.

UR - http://www.scopus.com/inward/record.url?scp=0021888024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021888024&partnerID=8YFLogxK

U2 - 10.1001/archopht.1985.01050060100036

DO - 10.1001/archopht.1985.01050060100036

M3 - Article

C2 - 3873931

AN - SCOPUS:0021888024

VL - 103

SP - 840

EP - 841

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 6

ER -